Clarity Pharmaceuticals Ltd.ASX: CU6

50% recruitment milestone reached for prostate cancer trial

Oct 27, 2022 at 3:10 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment